Immunotherapy with dendritic cells derived from bone marrow hematopoietic stems cells inhibited tumor growth on a TRAMP-C1 syngeneic mouse model of prostate cancer

Immunotherapy with dendritic cells derived from bone marrow hematopoietic stems cells inhibited tumor growth on a TRAMP-C1 syngeneic mouse model of prostate cancer

Bibliographic Details
Main Authors:	B. Lim, W Lee, Y.S. Kyung, Y. Kim, K. Bong-Min, M.Y. Park, H. Lee, H. Kim, Y. Dalsan, I.G. Jeong, C. Kim
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320338337

Similar Items

Application of immunotherapy based on dendritic cells stimulated by tumor cell-derived exosomes in a syngeneic breast tumor mouse model
by: Yin Ji Piao, et al.
Published: (2021-12-01)

Development of Pig Conventional Dendritic Cells From Bone Marrow Hematopoietic Cells in vitro
by: Yanli Li, et al.
Published: (2020-10-01)

Immunotherapy Using Dendritic Cells against Multiple Myeloma: How to Improve?
by: Thanh-Nhan Nguyen-Pham, et al.
Published: (2012-01-01)

Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure inhibit prostate tumor growth in TRAMP mice
by: Romana Mikyskova, et al.
Published: (2017-12-01)

THE PHENOMENON OF TRAMP AND THE AMERICAN SYSTEM OF SEPARATION OF POWERS
by: N. V. Molchakov, et al.
Published: (2018-05-01)

Analysis of Allogeneic and Syngeneic Bone Marrow Stromal Cell Graft Survival in the Spinal Cord
by: Sharon A. Swanger, et al.
Published: (2005-11-01)

On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy
by: Benjamin Y. Kong, et al.
Published: (2019-02-01)

Effect of Low dose Radiation on Differentiation of Bone Marrow Cells into Dendritic Cells
by: Sung Hak Chun, et al.
Published: (2013-07-01)

Autologous Hematopoietic Stem Cells Are a Preferred Source to Generate Dendritic Cells for Immunotherapy in Multiple Myeloma Patients
by: Prajakta Shinde, et al.
Published: (2019-05-01)

Heterogeneity of porcine bone marrow-derived dendritic cells induced by GM-CSF.
by: Sang Eun Kim, et al.
Published: (2019-01-01)

Dendritic Cell-Based Immunotherapy for Prostate Cancer
by: Hanka Jähnisch, et al.
Published: (2010-01-01)

Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy
by: Sung-Yeon Cho, et al.
Published: (2019-05-01)

Etoposide-mediated interleukin-8 secretion from bone marrow stromal cells induces hematopoietic stem cell mobilization
by: Ka-Won Kang, et al.
Published: (2020-07-01)

Multimodality Imaging of Bone Marrow–Derived Dendritic Cell Migration and Antitumor Immunity
by: Su-Bi Ahn, et al.
Published: (2017-04-01)

Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis
by: Shuhei Kurosawa, et al.
Published: (2021-09-01)

Dendritic Cells and Their Role in Immunotherapy
by: Alycia Gardner, et al.
Published: (2020-05-01)

Systemic alkalinisation delays prostate cancer cell progression in TRAMP mice
by: Simonetta Astigiano, et al.
Published: (2017-01-01)

Tramp shipping
by: Long, Sumner Adam
Published: (2017)

MHC-Linked Syngeneic Developmental Preference inThymic Lobes Colonized with Bone Marrow Cells: A Mathematical model
by: Amiela Globerson, et al.
Published: (1998-01-01)

Dendritic Cell-Based Immunotherapy for Solid Tumors
by: Nam-Chul Jung, et al.
Published: (2018-06-01)

СORRECTION OF AUTOIMMUNE GLOMERULONEPHRITIS BY LETHAL IRRADIATION AND TRANSFER OF SYNGENEIC BONE MARROW CELLS IN AN EXPERIMENTAL MODEL
by: O. T. Kudaeva, et al.
Published: (2014-07-01)

Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study
by: Jeong-Hoon Lee, et al.
Published: (2017-07-01)

Reconstruction of the Hematopoietic System after Stem Cell Transplantation
by: M.Y. Gordon, et al.
Published: (1998-07-01)

Immune Profiling of Syngeneic Murine and Patient GBMs for Effective Translation of Immunotherapies
by: Jasneet Kaur Khalsa, et al.
Published: (2021-02-01)

The effector cells in in vitro semi-syngeneic cytotoxicity and their functions in the in vivo phenomenon of the graft-versus-host reaction
by: Fung, Kenneth K. Y.
Published: (2013)

The effector cells in in vitro semi-syngeneic cytotoxicity and their functions in the in vivo phenomenon of the graft-versus-host reaction
by: Fung, Kenneth K. Y.
Published: (2013)

Melanoma immunotherapy: dendritic cell vaccines
by: Ivan Lozada-Requena, et al.
Published: (2015-09-01)

Dendritic cell vaccines in tumor immunotherapy
by: Wurzenberger, Cornelia
Published: (2009)

MHC Class I Expression by Donor Hematopoietic Stem Cells Is Required to Prevent NK Cell Attack in Allogeneic, but Not Syngeneic Recipient Mice.
by: Yuichi Hirata, et al.
Published: (2015-01-01)

MSCs Become Collagen-Type I Producing Cells with Different Phenotype in Allogeneic and Syngeneic Bone Marrow Transplantation
by: Robert Maximilian Rusch, et al.
Published: (2021-05-01)

Sources of Human Hematopoietic Stem Cells for Transplantation–A Review
by: T.A.S. Amos, et al.
Published: (1995-11-01)

Genistein chemoprevention of prostate cancer in TRAMP mice
by: Wang Jun, et al.
Published: (2007-03-01)

Biomechanical forces enhance directed migration and activation of bone marrow-derived dendritic cells
by: Ji-Hun Kang, et al.
Published: (2021-06-01)

Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models
by: Jonathan Rios-Doria, et al.
Published: (2015-08-01)

Immune Suppressive Effects of Tonsil-Derived Mesenchymal Stem Cells on Mouse Bone-Marrow-Derived Dendritic Cells
by: Minhwa Park, et al.
Published: (2015-01-01)

Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8+ T cells for cancer immunotherapy
by: Jung, K., et al.
Published: (2022)

IL-2 and Anti-TGF-β Promote NK Cell Reconstitution and Anti-tumor Effects after Syngeneic Hematopoietic Stem Cell Transplantation
by: Maite Alvarez, et al.
Published: (2020-10-01)

Cell-permeable transgelin-2 as a potent therapeutic for dendritic cell-based cancer immunotherapy
by: Hye-Ran Kim, et al.
Published: (2021-03-01)

Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy
by: Xin Peng, et al.
Published: (2021-02-01)

Dendritic Cell-Based Immunotherapy in Lung Cancer
by: Dieter Stevens, et al.
Published: (2021-02-01)